share_log

BioCryst Pharmaceuticals Price Target Raised to $19.00/Share From $14.00 by HC Wainwright & Co.

Dow Jones Newswires ·  Mar 24, 2021 18:48

DJ BioCryst Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Ratings actions from Benzinga: https://www.benzinga.com/stock/BCRX/ratings

(END) Dow Jones Newswires

March 24, 2021 06:48 ET (10:48 GMT)

DJ BioCryst Pharmaceuticals Price Target Raised to $19.00/Share From $14.00 by HC Wainwright & Co.

Ratings actions from Benzinga: https://www.benzinga.com/stock/BCRX/ratings

(END) Dow Jones Newswires

March 24, 2021 06:48 ET (10:48 GMT)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment